Is paclitaxel/carboplatin really a useful regimen for ovarian cancer compared with platinum/doxorubicin/cyclophosphamide?
- PMID: 16850120
- DOI: 10.1007/s10147-006-0572-7
Is paclitaxel/carboplatin really a useful regimen for ovarian cancer compared with platinum/doxorubicin/cyclophosphamide?
Comment on
-
Historical control study of paclitaxel-carboplatin (TJ) versus conventional platinum-based chemotherapy (CAP) for epithelial ovarian cancer.Int J Clin Oncol. 2006 Jun;11(3):221-8. doi: 10.1007/s10147-005-0555-0. Int J Clin Oncol. 2006. PMID: 16850129